NEO2734

Item number	Size	Delivery time	Price
TGM-T8658-1mg	1 mg	7 - 10 business days*	109.00€
TGM-T8658-5mg	5 mg	7 - 10 business days*	273.00€
TGM-T8658-1mL	1 ml	7 - 10 business days*	300.00€
TGM-T8658-10mg	10 mg	7 - 10 business days*	452.00€
TGM-T8658-25mg	25 mg	7 - 10 business days*	747.00€
TGM-T8658-50mg	50 mg	7 - 10 business days*	1,023.00€
TGM-T8658-100mg	100 mg	7 - 10 business days*	1,402.00€
TGM-T8658-500mg	500 mg	7 - 10 business days*	2,817.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: NEO2734 (EP31670) is an orally active, selective inhibitor of p300/CBP and BET... more

Close menu

Product information "NEO2734"

Description: NEO2734 (EP31670) is an orally active, selective inhibitor of p300/CBP and BET bromodomains, with an IC50 of less than 30 nM for both targets. Target: Histone Acetyltransferase, Epigenetic Reader Domain. Smiles: Cc1cc(cn(C)c1=O)-c1ccc2nc(C3CCOCC3)n(CCOC(F)(F)F)c2c1. References: The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer

Keywords:	EP31670
Supplier:	TargetMol
Supplier-Nr:	T8658

Properties

Application:	p300/CBP / BET bromodomains dual inhibitor
MW:	435.44 D
Formula:	C22H24F3N3O3

Database Information

CAS :	2081072-29-7\| Matching products
KEGG ID :	K04498 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "NEO2734"

Write a review